NSEAnalysts/Institutional Investor Meet/Con. Call Updates5d ago · 17 Jul 2026, 12:29 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Indoco Remedies Limited · INDOCO
✦ AI SummaryResults
Indoco Remedies Limited has scheduled an earnings conference call for Q1 FY2026-2027 on July 28, 2026, to discuss unaudited financial results for the quarter ended June 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Indoco Remedies Limited has informed the Exchange about Schedule of meet
Attachments (1)
📄pdf
Download →
INDOCO_17072026122746_INTIMATIONSTKECC280726merged.pdf
View document text
17th July, 2026
To To
The Listing Department The Listing Department
National Stock Exchange of India Limited Bombay Stock Exchange Limited
Exchange Plaza, Floor 25, P. J. Towers,
Bandra – Kurla Complex Dalal Street,
Bandra (East) Mumbai – 400 001
Mumbai – 400 051 Stock Code : 532612
Stock Code : INDOCO
Dear Sir/Madam,
Subject: Intimation of Earnings Conference Call on Unaudited Financial Results for
Quarter Ended 30th June, 2026
Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015, we wish to inform you that an Earnings
Conference Call on Unaudited Financial Results for the Quarter Ended 30th June, 2026 is
scheduled to be held on Tuesday, 28th July, 2026 at 03:30 P.M. IST.
The details of the conference call are enclosed herewith.
This is for your information and dissemination on respective websites.
Thanking you,
Yours faithfully,
For Indoco Remedies Limited
Ramanathan Hariharan
Company Secretary & Head Legal
You are cordially invited to the
Q1 FY2026-2027 Earnings Conference Call of
Indoco Remedies Limited
Tuesday, July 28, 2026 at 3:30PM IST
Represented by:
Ms. Aditi Panandikar Managing Director
Mr. Sundeep V. Bambolkar Jt. Managing Director
Mr. Pramod Ghorpade CFO
Pre-register to avoid the waiting queue, join with DiamondPass link: Registration Link
Conference Dial-In Number
+91 22 6280 1116
Universal Access
+91 22 7115 8017
Hong Kong: 800 964 448
Singapore: 800 101 2045
International Toll Free
USA: 1 866 746 2133
UK: 0 808 101 1573
For further information, please contact:
Rashmi Shetty Candice Pereira Zain Gulam Hussain
Director - Research AVP Research Associate
Dolat Capital Market Pvt. Ltd. Dolat Capital Market Pvt. Ltd. Dolat Capital Market Pvt. Ltd.
(D) +91 22 40969724 (D) +91 22 61764873 (D) +91 22 40969790
(M) +91 22 8879111413 (M) +91 22 9833458572 (M) +91 22 9892724209
Email: rashmis@dolatcapital.com Email: candicep@dolatcapital.com Email: zain@dolatcapital.com